Hexagon Nutrition FY26 net profit rises 56% to ₹379.37 million
Hexagon Nutrition Limited reported a consolidated net profit of ₹379.37 million for FY26, a 56% increase from the previous year, while revenue rose to ₹3,826.28 million. The board approved the audited financial results and re-appointed auditors for FY27. The auditor's report noted material uncertainties regarding foreign subsidiaries and details regarding the company's recent IPO.

*this image is generated using AI for illustrative purposes only.
Hexagon Nutrition Limited reported a consolidated net profit of ₹379.37 million for the financial year ended March 31, 2026, a 56% increase from ₹243.05 million in the previous year. Revenue from operations grew to ₹3,826.28 million from ₹3,249.29 million in FY25, driven by higher sales across its nutritional product segments. The company’s board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, during a meeting held on June 30, 2026.
For the quarter ended March 31, 2026, the company recorded a consolidated net profit of ₹109.04 million, compared to ₹77.64 million in the corresponding quarter of the previous year. Revenue from operations for the quarter stood at ₹1,150.41 million. Total comprehensive income for the year increased to ₹391.12 million from ₹232.36 million in the prior year. The earnings per share (EPS) on a basic basis for the year was ₹3.43, up from ₹1.75 in FY25.
Consolidated Financial Performance
| Particulars | Year Ended March 31, 2026 (₹ million) | Year Ended March 31, 2025 (₹ million) |
|---|---|---|
| Revenue from Operations | 3,826.28 | 3,249.29 |
| Total Income | 3,945.66 | 3,312.87 |
| Total Expenses | 3,436.92 | 2,967.76 |
| Profit Before Tax | 511.80 | 337.16 |
| Net Profit | 379.37 | 243.05 |
| Basic EPS (₹) | 3.43 | 1.75 |
The board also approved the re-appointment of M/S KPMSS & Associates as Cost Auditor and M/S Bhuwania & Agrawal Associates as Internal Auditor for the financial year 2026-27, subject to shareholder ratification. The company’s statutory auditor, S K Patodia & Associates LLP, issued an unmodified opinion on the financial results.
Key Disclosures
The auditor’s report highlighted an emphasis of matter regarding the merger of Hexagon Nutrition (Exports) Private Limited with the holding company, the conversion of Compulsorily Convertible Preference Shares (CCPS) into equity shares, and the subsequent listing of the company’s equity shares on June 12, 2026. Additionally, the report noted a material uncertainty regarding the ability of two foreign subsidiaries, Hexagon Nutrition Proprietary Ltd (South Africa) and Hexagon Nutrition LLC (Uzbekistan), to continue as a going concern due to historical accumulated losses, though the holding company has committed to providing financial support.
The company completed its Initial Public Offering (IPO) through a 100% Offer for Sale of 3,08,59,704 equity shares at an offer price of ₹45 per share, aggregating to ₹138.87 crores, prior to the listing date. The proceeds from the IPO were received by the selling shareholders, and the company did not receive any funds from the issue.
What specific strategic measures will Hexagon Nutrition implement to resolve the material uncertainty regarding the going concern status of its South African and Uzbek subsidiaries?
How does the company plan to utilize its recent listing status to drive further growth in international markets?
What are the management's revenue and profit growth projections for FY27 following the strong performance in FY26?






















